Development Level

Tbio 21 | 10,625
Tchem 2 | 1,890
Tclin 1 | 602

IMPC Term

preweaning lethality, complete... 2 | 633
abnormal behavior 1 | 226
abnormal behavioral response t... 1 | 52
abnormal cranium morphology 1 | 32
abnormal embryo size 1 | 112
abnormal external female genit... 1 | 1
abnormal external male genital... 1 | 1
abnormal facial morphology 1 | 9
abnormal femur morphology 1 | 14
abnormal head morphology 1 | 10
abnormal head shape 1 | 4
abnormal humerus morphology 1 | 11
abnormal joint morphology 1 | 14
abnormal limb morphology 1 | 7
abnormal outer ear morphology 1 | 1
abnormal tail morphology 1 | 17
abnormal tail movements 1 | 12
abnormal tibia morphology 1 | 14
abnormal ulna morphology 1 | 8
abnormal vertebrae morphology 1 | 14
cyanosis 1 | 6
decreased body length 1 | 108
decreased body weight 1 | 174
decreased bone mineral content 1 | 157
decreased circulating calcium ... 1 | 33
decreased circulating glucose ... 1 | 121
decreased circulating serum al... 1 | 79
decreased circulating total pr... 1 | 41
decreased lean body mass 1 | 195
decreased total body fat amoun... 1 | 186
hemorrhage 1 | 12
hyperactivity 1 | 108
hypoactivity 1 | 89
increased circulating chloride... 1 | 43
increased circulating glucose ... 1 | 16
increased circulating sodium l... 1 | 71
increased mean corpuscular hem... 1 | 25
increased sacral vertebrae num... 1 | 62
increased vertical activity 1 | 18
straub tail 1 | 26
vertebral fusion 1 | 23

Disease

osteosarcoma 13 | 7,933
psoriasis 13 | 6,685
glioblastoma 12 | 5,572
ovarian cancer 12 | 8,484
medulloblastoma, large-cell 10 | 6,234
Cancer 8 | 2,346
Pick disease 7 | 1,893
group 3 medulloblastoma 7 | 2,254
intraductal papillary-mucinous neoplasm (IPMN) 7 | 3,289
malignant mesothelioma 7 | 3,162
pancreatic cancer 7 | 2,300
pilocytic astrocytoma 7 | 3,086
Breast cancer 6 | 3,094
astrocytoma 6 | 1,493
atypical teratoid / rhabdoid tumor 6 | 4,369
ductal carcinoma in situ 6 | 1,745
ependymoma 6 | 2,514
invasive ductal carcinoma 6 | 2,950
tuberculosis 6 | 1,557
ulcerative colitis 6 | 2,087
Carcinoma 5 | 2,147
cystic fibrosis 5 | 1,665
group 4 medulloblastoma 5 | 1,875
interstitial cystitis 5 | 2,299
intraductal papillary-mucinous carcinoma (IPMC) 5 | 2,988
lung cancer 5 | 4,466
lung carcinoma 5 | 2,844
non-small cell lung cancer 5 | 2,798
Amyotrophic Lateral Sclerosis 4 | 431
acute quadriplegic myopathy 4 | 1,157
adrenocortical carcinoma 4 | 1,427
adult high grade glioma 4 | 2,148
breast carcinoma 4 | 1,614
dermatomyositis 4 | 933
fibroadenoma 4 | 557
intraductal papillary-mucinous adenoma (IPMA) 4 | 2,956
oligodendroglioma 4 | 2,849
pediatric high grade glioma 4 | 2,712
posterior fossa group A ependymoma 4 | 1,511
primary pancreatic ductal adenocarcinoma 4 | 1,271
primitive neuroectodermal tumor 4 | 3,031
astrocytic glioma 3 | 2,241
atypical teratoid/rhabdoid tumor 3 | 1,095
autosomal dominant Emery-Dreifuss muscular dystrophy 3 | 499
colon cancer 3 | 1,475
cutaneous lupus erythematosus 3 | 1,056
diabetes mellitus 3 | 1,663
gastric carcinoma 3 | 832
juvenile dermatomyositis 3 | 1,189
pancreatic ductal adenocarcinoma liver metastasis 3 | 1,795
sonic hedgehog group medulloblastoma 3 | 1,482
tuberculosis and treatment for 3 months 3 | 327
Atopic dermatitis 2 | 944
Crohn's disease 2 | 304
Microcephaly 2 | 149
Multiple Sclerosis 2 | 498
Neurodegenerative disease 2 | 383
Rheumatoid Arthritis 2 | 1,160
Robinow syndrome 2 | 12
active Crohn's disease 2 | 918
esophageal adenocarcinoma 2 | 737
gastric cancer 2 | 430
head and neck cancer 2 | 270
lung adenocarcinoma 2 | 2,713
non primary Sjogren syndrome sicca 2 | 840
posterior fossa group B ependymoma 2 | 1,530
progressive supranuclear palsy 2 | 674
spina bifida 2 | 1,064
subependymal giant cell astrocytoma 2 | 2,287
Acute myeloid leukemia, disease 1 | 16
Barrett's esophagus 1 | 183
Celiac disease 1 | 112
Charcot-Marie-Tooth disease 1 | 74
Chronic Lymphocytic Leukemia 1 | 242
Cleft palate 1 | 125
Cleidocranial dysplasia 1 | 10
Colorectal Neoplasms 1 | 217
Craniofacial Abnormalities 1 | 147
Dental caries 1 | 67
Early infantile epileptic encephalopathy with suppression bursts 1 | 18
Familial adenomatous polyposis 1 | 31
Filariasis 1 | 21
Hodgkin's lymphoma 1 | 11
Japanese encephalitis 1 | 6
Liver cancer 1 | 31
Lung Neoplasms 1 | 171
Lynch syndrome 1 | 33
Malignant tumor of ovary 1 | 25
Metastatic Breast Carcinoma 1 | 21
Osteogenesis imperfecta 1 | 34
Osteonecrosis 1 | 25
Progressive relapsing multiple sclerosis 1 | 18
Seckel syndrome 1 | 34
Uterine Cervical Neoplasm 1 | 21
X-linked cerebral adrenoleukodystrophy 1 | 115
facioscapulohumeral dystrophy 1 | 286
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
interstitial lung disease 1 | 291
non-inflammatory breast cancer 1 | 208
tick-borne encephalitis 1 | 14

Tissue

Blood and immune system 24 | 17,995
Cardiovascular System 24 | 17,958
Digestive Tract 24 | 18,473
Endocrine System 24 | 18,512
Female tissues 24 | 18,647
Liver and Pancreas 24 | 18,136
Male tissues 24 | 17,969
Nervous System 24 | 18,561
Respiratory system 24 | 17,484
Skin and soft tissues 24 | 18,115
Urinary Tract 24 | 18,444

Target Family

Non-IDG 16 | 11,971
Transcription Factor 4 | 1,400
Enzyme 3 | 4,146
GPCR 1 | 406

Grant Application

2P41RR000592-39 24 | 24
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Ras-related protein Rab-11A RAB11A Tbio Enzyme -2.60207 398.9 288
Tubulin delta chain TUBD1 Tbio Non-IDG -1.33485 22.2 51
Tubulin epsilon chain TUBE1 Tbio Non-IDG -2.56199 365.9 54
Frizzled-1 FZD1 Tbio GPCR -2.02978 74.3 233
WD repeat and FYVE domain-containing protein 2 WDFY2 Tbio Non-IDG -3.79727 6461.3 19
Protein Wnt-5a WNT5A Tbio Non-IDG -2.69880 587.4 277
Sarcospan SSPN Tbio Non-IDG -1.59336 44.6 35
Tensin-1 TNS1 Tbio Non-IDG -2.67038 318.0 121
IgG receptor FcRn large subunit p51 FCGRT Tchem Non-IDG -2.73048 598.8 158
Centromere protein J CENPJ Tbio Non-IDG -1.75521 57.1 86